Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/31/25 16:38 | 7/29/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Blum Robert I | CA | DO | P,CEO | 6 | S | -1,021 | 34.02 | 0 | -30 | 417 | D | |||||||||||||||
7/23/25 11:01 | 7/22/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 6 | S.d | -406 | 33.84 | 0 | -12 | 141 | D | |||||||||||||||
6/5/25 16:42 | 6/5/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Kaye Edward M. Md | CA | D | 1 | S | -117 | 32.10 | 0 | -4 | 30 | D | ||||||||||||||||
6/5/25 16:38 | 6/5/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Callos Andrew | CA | O | EVP,Chie | 2 | S | -424 | 33.51 | 0 | -13 | 61 | D | |||||||||||||||
5/15/25 18:51 | 5/15/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Bhanji Muna | CA | D | 1 | S | -43 | 29.73 | 0 | -1 | 24 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |